Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes


Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides


Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contact Us

Contact Customer Service

Special Offers

View our current special offers

Science Next Collaborative

The Science Next Collaborative (SNC) is a Sigma-Aldrich Australia initiative that aims to empower our world-class scientists

Redi-Dri™ for Free-Flowing Hygroscopic Powders

Redi-Dri packaging system eliminates clumping typically noted with many hygroscopic powders and provides a free-flowing, ready-to-use material.

Roche Biochemical Reagents

Roche's core Biochemical Reagents products are now available exclusively through Sigma-Aldrich

News & Information

St. Louis, MO - November 18, 2015 Merck KGaA, Darmstadt, Germany, Completes Sigma-Aldrich Acquisition

Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $130 billion global industry to help solve the toughest problems in life science.

Read More
St. Louis, MO - November 10, 2015 Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain EC Antitrust Approval and Work Toward Closing Planned Acquisition

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has secured final approval from the European Commission (EC) on the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany.

Read More
St. Louis, MO - November 4, 2015 Sigma-Aldrich Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has expanded its distribution agreements with GENEWIZ® and Oxford Genetics to provide customers with an easy-to-use, web-based ordering system that will provide instant pricing for most synthetic DNA up to 5kb.

Read More
St. Louis, MO - October 29, 2015 Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience

Offers exclusive technology as a faster path to understanding true disease biology

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that it has signed an agreement to acquire the Duolink® product portfolio from Olink Bioscience. The acquisition includes intellectual property, sales, marketing and manufacturing assets.

Read More